From Passion To Product to Patient ®

bcl-6

Anti-bcl-6 is a transcriptional regulator gene which codes for a 706-amino-acid nuclear zinc finger protein. Antibodies to this protein stain the germinal center cells in lymphoid follicles, the follicular cells and interfollicular cells in follicular lymphoma, diffuse large B-cell lymphomas, and Burkitt's lymphoma, and the majority of the Reed-Sternberg cells in nodular lymphocyte predominant Hodgkin's Disease. In contrast, anti-bcl-6 rarely stains mantle cell lymphoma and MALT lymphoma. Anti-bcl-6 expression is seen in approximately 45% of CD30+ anaplastic large cell lymphomas but is consistently absent in other peripheral T-cell lymphomas. bcl-6 is protected by U.S. patents 6,174,997 and 6,783,94 (Cancer Genetics, Inc.)

 Mouse Monoclonal, Clone: GI191E/A8
    0.1 ml concentrated227M-94
    0.5 ml concentrated227M-95
    1 ml concentrated227M-96
    1 ml prediluted227M-97
    7 ml prediluted227M-98
    Ventana®* dispenser760-4241
    5 Positive Control Slides 227S
Regulatory Status

USIVD
CanadaIVD
European UnionIVD
AustraliaIVD
JapanRUO



Site Map | Privacy Policy/Terms of Use
©2010 Cell Marque Corporation All Rights Reserved